Cardinal Health, US14149Y1082

Cardinal Health stock gains 0.16 percent pre-market to EUR 213.50

Published on 10/09/2026 at 07:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cardinal Health stock was EUR 213.50 pre-market at Lang & Schwarz at 7:34 a.m. CEST on October 9, 2026, up 0.16 percent. Fiscal 2027 first-quarter results are scheduled for November 5.

Key points in brief

  • Cardinal Health stock was EUR 213.50 pre-market at 7:34 a.m. CEST.
  • The price was up 0.16 percent versus the Lang & Schwarz prior close.
  • Fiscal 2027 first-quarter results are scheduled for November 5, 2026.
Schwarzweiß-Reportage an der Verladerampe eines Pharma-Distributionszentrums
Cardinal Health Inc. zeigt eine SW-Reportage der Verladerampe im Pharma-Lager ISIN US14149Y1082, Illustration mit AI erstellt.

Cardinal Health stock was EUR 213.50 pre-market at Lang & Schwarz at 7:34 a.m. CEST on October 9, 2026, up 0.16 percent versus the EUR 213.15 prior close from October 8. The quote was EUR 0.35 higher than the reference price.

Pre-market trading

Lang & Schwarz listed a bid of EUR 212.10 and an ask of EUR 214.90. The pre-market indication comes before the Xetra session begins at 9:00 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Cardinal Health stock.

What matters today

Cardinal Health is scheduled to release fiscal 2027 first-quarter results on November 5, 2026, before trading begins on the New York Stock Exchange, with a webcast at 8:30 a.m. Eastern, according to the Cardinal Health newsroom. The next round-number price level is EUR 220.00, which is 3.04 percent above the pre-market price. Cardinal Health's trailing dividend yield was 1.00 percent as of October 8, 2026.

Market context: Market report S&P 500.

More news and analysis on Cardinal Health stock

Disclaimer...

en | US14149Y1082 | CARDINAL HEALTH | boerse | 70272079 | bgmi